Alcon Inc - Company Profile
Powered by 
All the data and insights you need on Alcon Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Alcon Inc Strategy Report
- Understand Alcon Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Alcon Inc (Alcon) is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for the prevention and cure of blindness and different eye diseases. Alcon’s pipeline products are developed through collaboration with institutions, medical innovators, research advisors and academic thought leaders. The company has operations in the Americas, Europe, the Middle East, and Africa and Asia Pacific. Alcon is headquartered in Fribourg, Switzerland.
Headquarters
Switzerland
Address
Rue Louis D Affry 6, Fribourg, Freiburg, 1701
Website
www.alcon.ch
No of Employees
25,315
Industry
Medical Equipment
Ticker Symbol & Exchange
ALC (SWF)
Revenue (2022)
$9.5B
8.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
190.7%
(2022 vs 2021)
Market Cap*
$39.9B
Net Profit Margin (2022)
XYZ
168.2%
(2022 vs 2021)
* As of and is in US$
Alcon Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Vision Care: | Total |
| Contact Lenses | Precision |
| Ocular Health Products | Systane |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Plans/Strategy | In February, the company announced its plans to launch the new MARLO App. |
| 2024 | New Products/Services | In February, the company introduced the TOTAL30 Multifocal in Canada. |
| 2023 | New Products/Services | In November, the company launched Clareon Vivity, the first and only non-diffractive extended depth of focus (EDOF) intraocular lens. |
Competitor Comparison
| Key Parameters | Alcon Inc | Johnson & Johnson | AbbVie Inc | EssilorLuxottica SA | Konica Minolta Inc |
|---|---|---|---|---|---|
| Headquarters | Switzerland | United States of America | United States of America | France | Japan |
| City | Fribourg | New Brunswick | North Chicago | Charenton-Le-Pont | Chiyoda-Ku |
| State/Province | Freiburg | New Jersey | Illinois | Ile-de-France | Tokyo |
| No. of Employees | 25,315 | 131,900 | 50,000 | 191,706 | 39,775 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| F. Michael Ball | Chairman | Executive Board | 2019 | 68 |
| David J. Endicot | Director; Chief Executive Officer | Executive Board | 2019 | 58 |
| Timothy C. Stonesifer | Chief Financial Officer | Senior Management | 2019 | 56 |
| Franck Leveiller | Chief Scientific Officer; Head - Global R&D; Senior Vice President | Senior Management | - | - |
| Sue-Jean Lin | Chief Information and Transformation Officer; Senior Vice President | Senior Management | 2018 | 65 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward